Danielle Kirkey

6PUBLICATIONS
26CO-AUTHORS
Haematological tumoursMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 12, 2026
Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity.

|Sep 08, 2025
Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma.

Michelle Choe, Danielle Kirkey, Isabel Lira

|Jan 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.

Katherine Tarlock, Robert B Gerbing, Rhonda E Ries

|Jan 03, 2023
Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia.

Quy Le, Thao Tang, Amanda Leonti

|Sep 23, 2022
Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1-antibody-drug conjugate.

Thao Tang, Quy Le, Sommer Castro

|Aug 19, 2022
Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia.

Danielle C Kirkey, Anisha M Loeb, Sommer Castro

Pageof 1

Frequent Collaborators

3 joint publications

Keith R Loeb

3 joint publications

Jack H Peplinski

2 joint publications

Rhonda Ries

2 joint publications

Benjamin J Huang